Recently, Fleischman et al. reported that Jak-2 V617F activity is positively correlated with TNF-α mRNA expression, suggesting that Jak2 V617F directly up regulates TNF-α mRNA in myeloproliferative neoplasm (MPN) patients [4]. Here, JAK2 is linked to myeloproliferative disorder.